# Medications for the Treatment of Dysthymic Disorder and Double Depression

> **NCT00234312** · PHASE4 · COMPLETED · sponsor: **Oregon Health and Science University** · enrollment: 40 (—)

## Conditions studied

- Depression
- Dysthymia

## Interventions

- **DRUG:** escitalopram and sertraline

## Key facts

- **NCT ID:** NCT00234312
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2006-10
- **Final completion:** 2006-10
- **Target enrollment:** 40 (—)
- **Last updated:** 2019-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00234312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00234312, "Medications for the Treatment of Dysthymic Disorder and Double Depression". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00234312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*